Capobianco, Marco, Department of Neurology, Regionale Multiple Sclerosis Centre (CReSM), University-hospital San Luigi Gonzaga, Orbassano, Italy
-
Vol 20, No 1 (2019) - Original research
The Value and Sustainability of Ocrelizumab in Relapsing Multiple Sclerosis: A Cost-Effectiveness and Budget Impact Analysis
Abstract HTML PDF
ISSN: 2240-256X